Dr. Jalbout holds a PhD in Physics (at the age of 19) with management degrees. He has lead many successful industrial projects. Additionally from a scientific point of view Dr. Jalbout hold over 400 scientific publications, 3000 citations and several patent disclosures.

Dr. Bang Xu graduated from East China University of Chemical Technology and received his PhD from the University of Arkansas in chemical engineering. He has over 30 years of experience in chemical engineering. Dr. Xu has also worked with large integrated majors including the world leader in GTL that is ConocoPhillips. The company Dr. Xu founded, Dason Technology has several multi-million dollar contracts from large Chinese corporations.

Dr. Khan serves as Chief Technology Officer for OxyVits and was previously medical director of the Intestine Transplant Program at the University of Arizona. He was also director of the Liver Transplant Program at the University of Arizona and specializes in the treatment of patients with short gut syndrome and liver failure induced by total parenteral nutrition. Currently, he is Professor of Surgery at Georgetown University.

Dr. Rilo serves as Chief Medical Officer for OxyVits and holds appointments as Professor of Surgery, Director of the Center for Cellular Transplantation, and Associate Director of the Arizona Diabetes Center at The University of Arizona in Tucson, Arizona. Prior to this he was Professor of Medicine at the University of Chicago and the University of Pittsburg. Dr. Rilo holds over 150 cientific publications and multiple patents.

Dr. Cao was previously senior technology manager, licensing officer and technology manager for more than six years at the University of Washington Center for Commercialization. Prior to this he was the technical director of Business Development for Cerep, Inc. in Redmond, Washington, and director of technology assessment and licensing at Molecumetics, Ltd., Bellevue, Washington.